Skip to primary navigation
Skip to main content
Skip to primary sidebar

Our Science
Our Programs
Our Team
Join Us
News & Events
Contact Us

Back to News & Media

05/22/2024

Eli Lilly inks deal worth over $1.1B to develop new radiopharmaceuticals

SHARE

SHARE

Privacy Policy Terms & Conditions

© Aktis Oncology 2021. All Rights Reserved.

Sign up for the latest from Aktis Oncology

Email address:

Leave this field empty if you're human: